These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
277 related articles for article (PubMed ID: 37360338)
21. Microglial Phagocytosis-Rational but Challenging Therapeutic Target in Multiple Sclerosis. Pinto MV; Fernandes A Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32825077 [TBL] [Abstract][Full Text] [Related]
22. Multiple functional therapeutic effects of DL-3-n-butylphthalide in the cuprizone model of demyelination. Wu Y; Dong L; Huang Q; Sun L; Liao Y; Tang Y; Wu Y Life Sci; 2019 Sep; 232():116501. PubMed ID: 31163175 [TBL] [Abstract][Full Text] [Related]
23. Novel cell-based analysis reveals region-dependent changes in microglial dynamics in grey matter in a cuprizone model of demyelination. Roufagalas I; Avloniti M; Fortosi A; Xingi E; Thomaidou D; Probert L; Kyrargyri V Neurobiol Dis; 2021 Sep; 157():105449. PubMed ID: 34274460 [TBL] [Abstract][Full Text] [Related]
24. Metformin Therapy Attenuates Pro-inflammatory Microglia by Inhibiting NF-κB in Cuprizone Demyelinating Mouse Model of Multiple Sclerosis. Abdi M; Pasbakhsh P; Shabani M; Nekoonam S; Sadeghi A; Fathi F; Abouzaripour M; Mohamed W; Zibara K; Kashani IR; Zendedel A Neurotox Res; 2021 Dec; 39(6):1732-1746. PubMed ID: 34570348 [TBL] [Abstract][Full Text] [Related]
25. Recent Advances on Immunosuppressive Drugs and Remyelination Enhancers for the Treatment of Multiple Sclerosis. Cadenas-Fernández J; Ahumada-Pascual P; Andreu LS; Velasco A Curr Pharm Des; 2021 Oct; 27(30):3273-3280. PubMed ID: 33504299 [TBL] [Abstract][Full Text] [Related]
26. Chronic Demyelination and Axonal Degeneration in Multiple Sclerosis: Pathogenesis and Therapeutic Implications. Simkins TJ; Duncan GJ; Bourdette D Curr Neurol Neurosci Rep; 2021 Apr; 21(6):26. PubMed ID: 33835275 [TBL] [Abstract][Full Text] [Related]
27. Lipopolysaccharide delays demyelination and promotes oligodendrocyte precursor proliferation in the central nervous system. Skripuletz T; Miller E; Grote L; Gudi V; Pul R; Voss E; Skuljec J; Moharregh-Khiabani D; Trebst C; Stangel M Brain Behav Immun; 2011 Nov; 25(8):1592-606. PubMed ID: 21635946 [TBL] [Abstract][Full Text] [Related]
28. Detrimental and protective action of microglial extracellular vesicles on myelin lesions: astrocyte involvement in remyelination failure. Lombardi M; Parolisi R; Scaroni F; Bonfanti E; Gualerzi A; Gabrielli M; Kerlero de Rosbo N; Uccelli A; Giussani P; Viani P; Garlanda C; Abbracchio MP; Chaabane L; Buffo A; Fumagalli M; Verderio C Acta Neuropathol; 2019 Dec; 138(6):987-1012. PubMed ID: 31363836 [TBL] [Abstract][Full Text] [Related]
29. Age Influences Microglial Activation After Cuprizone-Induced Demyelination. Klein B; Mrowetz H; Barker CM; Lange S; Rivera FJ; Aigner L Front Aging Neurosci; 2018; 10():278. PubMed ID: 30297998 [TBL] [Abstract][Full Text] [Related]
30. High-Resolution Transcriptomic and Proteomic Profiling of Heterogeneity of Brain-Derived Microglia in Multiple Sclerosis. Miedema A; Wijering MHC; Eggen BJL; Kooistra SM Front Mol Neurosci; 2020; 13():583811. PubMed ID: 33192299 [TBL] [Abstract][Full Text] [Related]
32. Drug-induced microglial phagocytosis in multiple sclerosis and experimental autoimmune encephalomyelitis and the underlying mechanisms. Ju WY; Wang Q; Song LJ; Ding ZB; Li XH; Kumar G; Yan Y; Ma CG Mol Biol Rep; 2023 Jan; 50(1):749-759. PubMed ID: 36309614 [TBL] [Abstract][Full Text] [Related]
33. Microglial aryl hydrocarbon receptor enhances phagocytic function via SYK and promotes remyelination in the cuprizone mouse model of demyelination. Wang Y; Sun J; Zhu K; Wang D; Zhao X; Zhang H; Wu S; Wang Y; Wang J J Neuroinflammation; 2023 Mar; 20(1):83. PubMed ID: 36966295 [TBL] [Abstract][Full Text] [Related]
34. Galectin-4, a Negative Regulator of Oligodendrocyte Differentiation, Is Persistently Present in Axons and Microglia/Macrophages in Multiple Sclerosis Lesions. de Jong CGHM; Stancic M; Pinxterhuis TH; van Horssen J; van Dam AM; Gabius HJ; Baron W J Neuropathol Exp Neurol; 2018 Nov; 77(11):1024-1038. PubMed ID: 30252090 [TBL] [Abstract][Full Text] [Related]
35. Remyelination in multiple sclerosis from the miRNA perspective. Maciak K; Dziedzic A; Saluk J Front Mol Neurosci; 2023; 16():1199313. PubMed ID: 37333618 [TBL] [Abstract][Full Text] [Related]
36. The good, the bad and the ugly. Macrophages/microglia with a focus on myelin repair. Doring A; Yong VW Front Biosci (Schol Ed); 2011 Jun; 3(3):846-56. PubMed ID: 21622236 [TBL] [Abstract][Full Text] [Related]
37. Astrocytes regulate myelin clearance through recruitment of microglia during cuprizone-induced demyelination. Skripuletz T; Hackstette D; Bauer K; Gudi V; Pul R; Voss E; Berger K; Kipp M; Baumgärtner W; Stangel M Brain; 2013 Jan; 136(Pt 1):147-67. PubMed ID: 23266461 [TBL] [Abstract][Full Text] [Related]
38. The endocannabinoid 2-AG enhances spontaneous remyelination by targeting microglia. Mecha M; Yanguas-Casás N; Feliú A; Mestre L; Carrillo-Salinas F; Azcoitia I; Yong VW; Guaza C Brain Behav Immun; 2019 Mar; 77():110-126. PubMed ID: 30582962 [TBL] [Abstract][Full Text] [Related]
39. Microglial Pruning: Relevance for Synaptic Dysfunction in Multiple Sclerosis and Related Experimental Models. Geloso MC; D'Ambrosi N Cells; 2021 Mar; 10(3):. PubMed ID: 33804596 [TBL] [Abstract][Full Text] [Related]
40. Fasudil enhances the phagocytosis of myelin debris and the expression of neurotrophic factors in cuprizone-induced demyelinating mice. Ding ZB; Han QX; Wang Q; Song LJ; Chu GG; Guo MF; Chai Z; Yu JZ; Xiao BG; Li XY; Ma CG Neurosci Lett; 2021 May; 753():135880. PubMed ID: 33838256 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]